Skip Navigation

This Article
Right arrow Print PDF (564K)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Weck, P. K.
Right arrow Articles by Goeddel, D. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weck, P. K.
Right arrow Articles by Goeddel, D. V.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 1981, Vol. 9, No. 22 6153-6166
© 1981


MOLECULAR BIOLOGY

Antiviral activities of hybrids of two major human leukocyte interferons

Phillip K. Weck*, Sharon Apperson*, Nowell Stebbing*, Patrick W. Gray+, David Leung+, H. Michael Shepard+ and David V. Goeddel+

*Department of Biology Genentech Inc. 460 Point San Bruno Boulevard, South San Francisco, CA 94080, USA +Department of Molecular Biology, Genentech Inc. 460 Point San Bruno Boulevard, South San Francisco, CA 94080, USA

Received August 3, 1981. Four hybrid human leukocyte interferon (LeIF or IFN-{alpha}) genes have been constructed by in vitro recombination of LeIF-A (IFN-{alpha}2) and LeIF-D (IFN-{alpha}l) genes at common restriction endonuclease sites located within their coding regions. These hybrid genes have been expressed in E. coli under trp promoter control. The interferons produced [LeIF-AD (BgIII]-AD (PvuII),-DA (BgIII),-DA (PvuII)] have antiviral properties distinct from the parental molecules LeIF-A and -D, varying considerably in their abilities to inhibit plaque formation by different viruses in a range of mammalian cells. All six of the cloned LeIFs exhibit the heat stability, pH 2 stability and antigenic specificity of natural leukocyte interferons.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Antimicrob. Agents Chemother.Home page
B. B. Gowen, D. L. Barnard, D. F. Smee, M.-H. Wong, A. M. Pace, K.-H. Jung, S. G. Winslow, K. W. Bailey, L. M. Blatt, and R. W. Sidwell
Interferon Alfacon-1 Protects Hamsters from Lethal Pichinde Virus Infection
Antimicrob. Agents Chemother., June 1, 2005; 49(6): 2378 - 2386.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
B. Cunningham, P Jhurani, P Ng, and J. Wells
Receptor and antibody epitopes in human growth hormone identified by homolog-scanning mutagenesis
Science, March 10, 1989; 243(4896): 1330 - 1336.
[Abstract] [PDF]


Home page
ScienceHome page
S. Rosenberg, E. Grimm, M McGrogan, M Doyle, E Kawasaki, K Koths, and D. Mark
Biological activity of recombinant human interleukin-2 produced in Escherichia coli
Science, March 30, 1984; 223(4643): 1412 - 1414.
[Abstract] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.